EUROFINS DISCOVERX
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

EUROFINS DISCOVERX Trademark

Serial Number: 79248150 • Registration: 6104027

EUROFINS DISCOVERX is a trademark filed by EUROFINS SCIENTIFIC (IRELAND) LIMITED Société de droit irlandais on September 7, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

EUROFINS SCIENTIFIC (IRELAND) LIMITED Société de droit irlandais

Clogherane
Dungarvan Co Waterford , IE

Entity Type: 99

Trademark Details

Filing Date

September 7, 2018

Registration Date

July 21, 2020

Published for Opposition

May 5, 2020

Goods & Services

Chemical preparations for discovery of new pharmaceutical products, not for medical use; diagnostic preparations used in science; diagnostic reagents for scientific use; test kits for analysis and diagnosis for scientific use and for use in the field of research, namely, reagents and buffers; chemical compounds for scientific use and for use in the field of research, and not for medical use, namely, oligonucleotides, polynucleotides, synthetic genes; oligonucleotide sequences for DNA microchips; gene libraries, namely, collections and variations of DNA fragments for scientific use; genetic engineering materials, namely, genes, fragments and combinations thereof for scientific use

DNA chips; peptide chips; DNA microchips; peptide microchips; biochips

Research and development in the fields of animal and plant biology, physical chemistry and microbiology; carrying out physical, chemical, physical-chemical, biochemical, biological or microbiological analyses in the fields of plant and animal products; carrying out physical, chemical, physical-chemical, biochemical, biological or microbiological analyses in the field of the food, chemical, pharmaceutical, cosmetic and environmental industry; carrying out genetic analyses in the fields of plant and animal products; carrying out genetic analyses in the food, chemical, pharmaceutical, cosmetic and environmental industries; carrying out nuclear magnetic resonance analyses in the food, chemical, pharmaceutical, cosmetic and environmental industries; scientific and industrial research; development of methods, namely, establishment and maintenance of chemical, biological and biomolecular testing methods; providing scientific, medical or industrial expert reports by scientists and engineers in the field of chemistry, biochemistry, immunology, pharmacology, biology and physiology for scientists and engineers; technical project studies; professional consultations in the field of scientific research and treatments in the field of chemistry, biochemistry, immunology, pharmacology, biology and physiology

Diagnostic preparations for medical and veterinary use; chemical analysis reagents for medical and veterinary use; biological reagents for medical and veterinary use, namely, reagents used for immunological methods, for the identification and quantification of protein type structures and fragments thereof; diagnostic reagents for medical and veterinary use; chemical reagents for medical and veterinary use; oligonucleotides and polynucleotides for medical and veterinary use; synthetic genes for medical and veterinary use; oligonucleotide sequences for DNA microchips for medical and veterinary use; gene libraries, namely, collections and variations of DNA fragments for medical and veterinary use, genetic engineering materials, namely, genes, fragments and combinations thereof for medical and veterinary use

Filing History

TEAS SECTION 71 & 15 RECEIVED
Jul 6, 2026 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 21, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 12, 2021 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Nov 10, 2020 XXSS
GENERIC MADRID TRANSACTION CREATED
Nov 10, 2020 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 21, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 21, 2020 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 12, 2020 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 27, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 27, 2020 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 5, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 5, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 26, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 26, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 26, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 26, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 26, 2020 CNEA
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Mar 25, 2020 GNS1
SUBSEQUENT FINAL EMAILED
Mar 25, 2020 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Mar 25, 2020 CFRC
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 5, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 5, 2020 CRFA
ASSIGNED TO LIE
Mar 2, 2020 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 26, 2020 ERFR
FINAL REFUSAL MAILED
Sep 5, 2019 CNFR
FINAL REFUSAL WRITTEN
Sep 5, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 6, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 6, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 6, 2019 TROA
REFUSAL PROCESSED BY IB
Mar 8, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 20, 2019 RFCS
REFUSAL PROCESSED BY MPU
Feb 20, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 8, 2019 RFCR
NON-FINAL ACTION WRITTEN
Feb 7, 2019 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Feb 7, 2019 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 29, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jan 28, 2019 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Jan 24, 2019 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 9, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jan 8, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 8, 2019 MAFR
ASSIGNED TO EXAMINER
Jan 3, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 3, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 27, 2018 REPR